Prilenia Therapeutics

Prilenia is a clinical stage biotechnology company developing novel treatments to slow the progression of neurodegenerative diseases and neurodevelopmental disorders.

Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o
Biotech

Longtime Takeda R&D chief to depart next June—Chutes & Ladders

Longtime Takeda R&D chief to depart next June. Sofinnova lands Gilead alum as executive partner. Pyxis locks in interim CEO before phase 1 results.
euro money cash coins Europe

Ferrer nabs European rights for ALS asset in €500M pact

Apr 28, 2025 2:40pm
parachute chutes

Lonza lands new CEO—Chutes & Ladders

Apr 5, 2024 8:30am
ALS spinal cord nervous system brain spine

Prilenia searches for positive signs in phase 2 ALS fail

Feb 23, 2023 11:15am